Twist Bioscience Corp — Institutional Ownership
Which tracked institutions hold TWST, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
24
Funds holding
$694918160
Total value held
Buying
16 added/new · 8 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $263943282 | 5554362 | -340610 | -5.78% |
| 2 | State Street Corp | $174430809 | 3670682 | +42864 | +1.18% |
| 3 | Goldman Sachs Group Inc | $81047546 | 1705546 | +8952 | +0.53% |
| 4 | Invesco Ltd. | $40927396 | 1290271 | -504872 | -28.12% |
| 5 | Bank Of America Corp /De/ | $27764083 | 584261 | +184907 | +46.30% |
| 6 | Morgan Stanley | $25986121 | 546845 | -319511 | -36.88% |
| 7 | Northern Trust Corp | $25088945 | 527966 | +23128 | +4.58% |
| 8 | Sei Investments Co | $16842064 | 354420 | — | NEW BUY |
| 9 | Citigroup Inc | $12728665 | 401282 | +307824 | +329.37% |
| 10 | Bank Of New York Mellon Corp | $8592423 | 180817 | -2124 | -1.16% |
| 11 | Principal Financial Group Inc | $5070954 | 106712 | — | NEW BUY |
| 12 | Franklin Resources Inc | $2469139 | 51960 | -1921 | -3.57% |
| 13 | Wells Fargo & Company/Mn | $2373243 | 74819 | +28059 | +60.01% |
| 14 | Ameriprise Financial Inc | $1582416 | 33300 | -48 | -0.14% |
| 15 | Royal Bank Of Canada | $1434000 | 30178 | — | NEW BUY |
| 16 | Janus Henderson Group Plc | $1216073 | 25580 | — | NEW BUY |
| 17 | Raymond James Financial Inc | $1043017 | 21949 | -1010 | -4.40% |
| 18 | Us Bancorp \De\ | $836257 | 17598 | -3768 | -17.64% |
| 19 | Barclays Plc | $539779 | 11359 | — | NEW BUY |
| 20 | Marex Group Plc | $451440 | 9500 | — | NEW BUY |
| 21 | Prudential Financial Inc | $450965 | 9490 | — | NEW BUY |
| 22 | Fifth Third Bancorp | $53591 | 1128 | — | NEW BUY |
| 23 | Pnc Financial Services Group, Inc. | $45524 | 958 | +453 | +89.70% |
| 24 | Amalgamated Financial Corp. | $428 | 8677 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.